China
Asia exits: Pass the parcel
Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk
China surgical robotics player RainMed raises $100m
Ping An Capital has led a Series D round of approximately $100 million for RainMed Medical, a China-based surgical robotics business. Other investors include Seresia Asset Management and Lighthouse Canton.
KKR promotes Chris Sun to partner
Chris Sun (pictured), a managing director at KKR who focuses on investments in China’s consumer sector, has been promoted to partner.
China 3D printing start-up WeNext raises $55m
Temasek Holdings, Cathay Capital Private Equity, and Haochen Capital have led a $55 million Series B round for WeNext Technology, a China-based 3D printing specialist.
China's Didi to delist in New York
China ride-hailing platform Didi, which has traded poorly ever since being targeted by regulators in the wake of its IPO in June, plans to delist from the New York Stock Exchange and relist in Hong Kong.
Wise Road buys semiconductor assets from Taiwan's ASE
Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to buy a package of assets from Taiwan-listed semiconductor business ASE Technology Holding for $1.46 billion.
China cleantech: Policy tailwinds
Private equity investment in China cleantech and renewables is at record levels, spurred by robust government support for the industry and a recognition that this time the boom might be sustainable
Lightspeed China closes US dollar fund at $920m
Lightspeed China Partners has closed its latest US dollar-denominated fund at $920 million. It is the largest fund raised by the firm and brings assets under management to $3 billion.
China procurement services start-up raises $102m
Chinese procurement management platform Going-Link, also known as Zhenyun, has raised a RMB650 million ($102 million) Series C round led by Meituan-backed DragonBall Capital.
Vision Fund joins $300m round for China vaccine developer
SoftBank Vision Fund 2 and 5Y Capital have led a $300 million Series C extension for Suzhou Abogen Biosciences, a Chinese vaccine developer focused on mRNA products, including one for COVID-19.
DCP leads $235m round for China's Datong Insurance
DCP Capital Partners has become the largest institutional shareholder in Datong Insurance Service, one of China’s leading insurance brokerages, after leading a RMB1.5 billion ($235 million) round.
Legend hits first close on healthcare fund, launches TMT vehicle
Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...
Qiming leads $40m round for Allorion Therapeutics
China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.
Secondaries supply-demand mismatch most extreme in Asia - AVCJ Forum
There is not enough capital in Asia to address the number of secondary opportunities – mirroring the situation globally – with investors claiming to have more transaction choices than ever before.
China GPU chip designer secures $313m Series A
Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.
China biotech IPOs in Hong Kong to stay strong - AVCJ Forum
The frenzy for Chinese biotech developers listing in Hong Kong is expected to continue well into 2022, industry participants told the AVCJ Private Equity & Venture Forum.
China ocular drugs developer raises $63m
China’s Neurophth Biotechnology, a gene therapy developer for ocular diseases, has raised a RMB400 million ($63 million) Series C round led by SDIC China Merchants Investment and Sequoia Capital China.
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
China IPOs: The star still wanes
Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence
Investors see China regulatory turbulence as short-term - AVCJ Forum
Regulatory uncertainty overshadowing China's technology sector is a temporary phenomenon, investors told the AVCJ Private Equity & Venture Forum, while noting that targeting areas favored by the government remains a safe play.
Vision Fund adds managing partners in India, China
SoftBank Vision Fund has promoted Sumer Juneja, who heads up its India investments, and Dennis Chang, a China-focused partner, to managing partner level.
Warburg Pincus backs China new materials business
Ambilight, a China-based new materials company focused on electrochromic (EC) components, has raised several hundred million dollars in Series C funding led by Warburg Pincus.
Local turbulence drives China tech players abroad - AVCJ Forum
Regulatory uncertainty in China has encouraged local technology companies to go global rather than rely on a single market, the AVCJ Private Equity & Venture Forum heard.